RHEACELL was honored by the organization ‘Dystrophic Epidermolysis Bullosa ResearchAssociation of America’ (debra) with the ‘Partners in Progress Award’, recognizing RHEACELL’s research commitment and medical advancements in the development of a therapy for the treatment of severe forms of Epidermolysis Bullosa.
[RHEACELL]